Decreased Tumor Progression and Invasion by a Novel Anti-Cell Motility Target for Human Colorectal Carcinoma Cells

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Jin, Qunyan ^a   Liu, Guangming ^a   Domeier, Phillip P ^a   Ding, Wei ^a   Mulder, Kathleen M ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EZRIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C FOS; PROTEIN KM23 1; REGULATOR PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ELK 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; COLLAGEN; CYTOPLASMIC DYNEIN; CYTOSKELETON PROTEIN; DRUG COMBINATION; DYNLRB1 PROTEIN, HUMAN; LAMININ; MATRIGEL; PROTEOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL MIGRATION; COCULTURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DRUG TARGETING; ENZYME ACTIVATION; FEMALE; FIBROBLAST; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MIGRATION INHIBITION; MITOGENESIS; MOUSE; NONHUMAN; PARACRINE SIGNALING; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TUMOR INVASION; ANIMAL; ANTAGONISTS AND INHIBITORS; CANCER TRANSPLANTATION; CELL MOTION; CHEMISTRY; COLORECTAL TUMOR; DIFFUSION CHAMBER; DRUG COMBINATION; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; LENTIVIRINAE; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; COLLAGEN; COLORECTAL NEOPLASMS; CYTOPLASMIC DYNEINS; CYTOSKELETAL PROTEINS; DIFFUSION CHAMBERS, CULTURE; DRUG COMBINATIONS; ETS-DOMAIN PROTEIN ELK-1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; LAMININ; LENTIVIRUS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS C-FOS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; TUMOR BURDEN;

EID: 84878660762     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066439     Document Type: Article

References (70)

1. Siegel R, Ward E, Brawley O, Jemal A, (2011) Cancer statistics (2011) The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236.
2. Friedl P, Alexander S, (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147: 992-1009.
3. Bierie B, Moses HL, (2006) Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6: 506-520.
4. Biname F, Lassus P, Hibner U, (2008) Transforming growth factor beta controls the directional migration of hepatocyte cohorts by modulating their adhesion to fibronectin. Mol Biol Cell 19: 945-956.
5. Roberts PJ, Der CJ, (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26: 3291-3310.
6. Dhillon AS, Hagan S, Rath O, Kolch W, (2007) MAP kinase signalling pathways in cancer. Oncogene 26: 3279-3290.
7. Huang C, Jacobson K, Schaller MD, (2004) MAP kinases and cell migration. J Cell Sci 117: 4619-4628.
8. Rajalingam K, Wunder C, Brinkmann V, Churin Y, Hekman M, et al. (2005) Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat Cell Biol 7: 837-843.
9. Chen H, Zhu G, Li Y, Padia RN, Dong Z, et al. (2009) Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Cancer research 69: 9228-9235.
10. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417: 949-954.
11. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, et al. (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532.
12. Yang SH, Sharrocks AD, (2006) Convergence of the SUMO and MAPK pathways on the ETS-domain transcription factor Elk-1. Biochemical Society symposium pp. 121-129.
13. Besnard A, Galan-Rodriguez B, Vanhoutte P, Caboche J, (2011) Elk-1 a transcription factor with multiple facets in the brain. Frontiers in neuroscience 5: 35.
14. Bahassi el M, Karyala S, Tomlinson CR, Sartor MA, Medvedovic M, et al. (2004) Critical regulation of genes for tumor cell migration by AP-1. Clin Exp Metastasis 21: 293-304.
15. Ozanne BW, Spence HJ, McGarry LC, Hennigan RF, (2007) Transcription factors control invasion: AP-1 the first among equals. Oncogene 26: 1-10.
16. Gao SY, Li EM, Cui L, Lu XF, Meng LY, et al. (2009) Sp1 and AP-1 regulate expression of the human gene VIL2 in esophageal carcinoma cells. J Biol Chem 284: 7995-8004.
17. Nowak D, Mazur AJ, Popow-Wozniak A, Radwanska A, Mannherz HG, et al. (2010) Subcellular distribution and expression of cofilin and ezrin in human colon adenocarcinoma cell lines with different metastatic potential. Eur J Histochem 54: e14.
18. Meng Y, Lu Z, Yu S, Zhang Q, Ma Y, et al. (2010) Ezrin promotes invasion and metastasis of pancreatic cancer cells. J Transl Med 8: 61.
19. Hayashi Y, Molina JR, Hamilton SR, Georgescu MM, (2010) NHERF1/EBP50 is a new marker in colorectal cancer. Neoplasia 12: 1013-1022.
20. Liu G, Ding W, Liu X, Mulder KM, (2006) c-Fos is required for TGFbeta1 production and the associated paracrine migratory effects of human colon carcinoma cells. Mol Carcinog 45: 582-593.
21. Vial E, Marshall CJ, (2003) Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells. J Cell Sci 116: 4957-4963.
22. Yue J, Mulder KM, (2001) Transforming growth factor-beta signal transduction in epithelial cells. Pharmacol Ther 91: 1-34.
23. Massague J, (2012) TGFbeta signalling in context. Nat Rev Mol Cell Biol 13: 616-630.
24. Buard A, Zipfel PA, Frey RS, Mulder KM, (1996) Maintenance of growth factor signaling through Ras in human colon carcinoma cells containing K-ras mutations. Int J Cancer 67: 539-546.
25. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, et al. (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338.
26. Massague J, (2008) TGFbeta in Cancer. Cell 134: 215-230.
27. Akhurst RJ, Hata A, (2012) Targeting the TGFbeta signalling pathway in disease. Nat Rev Drug Discov 11: 790-811.
28. Heldin CH, Vanlandewijck M, Moustakas A, (2012) Regulation of EMT by TGFbeta in cancer. FEBS letters 586: 1959-1970.
29. Loboda A, Nebozhyn MV, Watters JW, Buser CA, Shaw PM, et al. (2011) EMT is the dominant program in human colon cancer. BMC Med Genomics 4: 9.
30. Jin Q, Pulipati NR, Zhou W, Staub CM, Liotta LA, et al. (2012) Role of km23-1 in RhoA/actin-based cell migration. Biochem Biophys Res Commun 428: 333-338.
31. Tang Q, Staub CM, Gao G, Jin Q, Wang Z, et al. (2002) A novel transforming growth factor-beta receptor-interacting protein that is also a light chain of the motor protein dynein. Mol Biol Cell 13: 4484-4496.
32. Hall J, Song Y, Karplus PA, Barbar E, (2010) The crystal structure of dynein intermediate chain-light chain roadblock complex gives new insights into dynein assembly. The Journal of biological chemistry 285: 22566-22575.
33. Ilangovan U, Ding W, Zhong Y, Wilson CL, Groppe JC, et al. (2005) Structure and dynamics of the homodimeric dynein light chain km23. J Mol Biol 352: 338-354.
34. Jin Q, Ding W, Mulder KM, (2007) Requirement for the dynein light chain km23-1 in a Smad2-dependent transforming growth factor-beta signaling pathway. J Biol Chem 282: 19122-19132.
35. Jin Q, Ding W, Mulder KM, (2012) The TGFbeta receptor-interacting protein km23-1/DYNLRB1 plays an adaptor role in TGFbeta1 autoinduction via its association with Ras. J Biol Chem 287: 26453-26463.
36. Jin Q, Ding W, Staub CM, Gao G, Tang Q, et al. (2005) Requirement of km23 for TGFbeta-mediated growth inhibition and induction of fibronectin expression. Cell Signal 17: 1363-1372.
37. Jin Q, Zhong Y, Mulder KM, (2013) Requirement for protein kinase A in the phosphorylation of the TGFbeta receptor-interacting protein km23-1 as a component of TGFbeta downstream effects. Exp Cell Res 319: 897-907.
38. Mulder KM, Brattain MG (1989) Growth factor expression and response in human colon carcinoma cells. In Augenlicht L, editor. The cell and molecular biology of colon cancer. Boca Raton: LRC Press. pp. 45-67.
39. Jin Q, Gao G, Mulder KM, (2009) Requirement of a dynein light chain in TGFbeta/Smad3 signaling. J Cell Physiol 221: 707-715.
40. Pandey MK, Liu G, Cooper TK, Mulder KM, (2012) Knockdown of c-Fos suppresses the growth of human colon carcinoma cells in athymic mice. Int J Cancer 130: 213-222.
41. Link A, Shin SK, Nagasaka T, Balaguer F, Koi M, et al. (2009) JC virus mediates invasion and migration in colorectal metastasis. PloS one 4: e8146.
42. Yang HS, Matthews CP, Clair T, Wang Q, Baker AR, et al. (2006) Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 26: 1297-1306.
43. Yu X, Machesky LM, (2012) Cells assemble invadopodia-like structures and invade into matrigel in a matrix metalloprotease dependent manner in the circular invasion assay. PloS one 7: e30605.
44. Katz M, Amit I, Yarden Y, (2007) Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim Biophys Acta 1773: 1161-1176.
45. Oliveira C, Pinto M, Duval A, Brennetot C, Domingo E, et al. (2003) BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency. Oncogene 22: 9192-9196.
46. Yue J, Mulder KM, (2000) Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a smad-dependent pathway. J Biol Chem 275: 30765-30773.
47. Roberts AB, Sporn MB (1990) The transforming growth factor βs. In: Sporn, M.B. and Roberts, A.B., editors. Peptides, Growth Factors and Their Receptors Part I. Berlin: Springer-Verlag. pp. 419-472.
48. Kim SJ, Angel P, Lafyatis R, Hattori K, Kim KY, et al. (1990) Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol 10: 1492-1497.
49. Takakura M, Kyo S, Inoue M, Wright WE, Shay JW, (2005) Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells. Mol Cell Biol 25: 8037-8043.
50. Gille H, Kortenjann M, Thomae O, Moomaw C, Slaughter C, et al. (1995) ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J 14: 951-962.
51. Wang HJ, Zhu JS, Zhang Q, Sun Q, Guo H, (2009) High level of ezrin expression in colorectal cancer tissues is closely related to tumor malignancy. World J Gastroenterol 15: 2016-2019.
52. Ren L, Hong SH, Chen QR, Briggs J, Cassavaugh J, et al. (2012) Dysregulation of ezrin phosphorylation prevents metastasis and alters cellular metabolism in osteosarcoma. Cancer research 72: 1001-1012.
53. Naumovski L, Sirisawad M, Lecane P, Chen J, Ramos J, et al. (2006) Tumor localization and antitumor efficacy of novel sapphyrin compounds. Mol Cancer Ther 5: 2798-2805.
54. Kohno M, Pouyssegur J, (2006) Targeting the ERK signaling pathway in cancer therapy. Annals of medicine 38: 200-211.
55. Miertzschke M, Koerner C, Vetter IR, Keilberg D, Hot E, et al. (2011) Structural analysis of the Ras-like G protein MglA and its cognate GAP MglB and implications for bacterial polarity. EMBO J 30: 4185-4197.
56. Odrowaz Z, Sharrocks AD, (2012) The ETS transcription factors ELK1 and GABPA regulate different gene networks to control MCF10A breast epithelial cell migration. PloS one 7: e49892.
57. Thiery JP, (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
58. Simms NA, Rajput A, Sharratt EA, Ongchin M, Teggart CA, et al. (2012) Transforming growth factor-beta suppresses metastasis in a subset of human colon carcinoma cells. BMC cancer 12: 221.
59. Singh N, Liu G, Chakrabarty S, (2013) Isolation and characterization of calcium sensing receptor null cells: A highly malignant and drug resistant phenotype of colon cancer. Int J Cancer 132: 1996-2005.
60. Giampieri S, Manning C, Hooper S, Jones L, Hill CS, et al. (2009) Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 11: 1287-1296.
61. Ono H, Imoto I, Kozaki K, Tsuda H, Matsui T, et al. (2012) SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation. Oncogene 31: 4923-4934.
62. Kanthan R, Senger JL, Kanthan SC, (2012) Molecular events in primary and metastatic colorectal carcinoma: a review. Patholog Res Int 2012: 597497.
63. Karydis A, Jimenez-Vidal M, Denker SP, Barber DL, (2009) Mislocalized scaffolding by the Na-H exchanger NHE1 dominantly inhibits fibronectin production and TGF-beta activation. Mol Biol Cell 20: 2327-2336.
64. Xie JJ, Xu LY, Xie YM, Zhang HH, Cai WJ, et al. (2009) Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells. Int J Cancer 124: 2549-2558.
65. Sperka T, Geissler KJ, Merkel U, Scholl I, Rubio I, et al. (2011) Activation of Ras requires the ERM-dependent link of actin to the plasma membrane. PloS one 6: e27511.
66. Briggs JW, Ren L, Nguyen R, Chakrabarti K, Cassavaugh J, et al. (2012) The ezrin metastatic phenotype is associated with the initiation of protein translation. Neoplasia 14: 297-310.
67. Wang B, Means CK, Yang Y, Mamonova T, Bisello A, et al. (2012) Ezrin-anchored protein kinase A coordinates phosphorylation-dependent disassembly of a NHERF1 ternary complex to regulate hormone-sensitive phosphate transport. J Biol Chem 287: 24148-24163.
68. Jarnaess E, Ruppelt A, Stokka AJ, Lygren B, Scott JD, et al. (2008) Dual specificity A-kinase anchoring proteins (AKAPs) contain an additional binding region that enhances targeting of protein kinase A type I. J Biol Chem 283: 33708-33718.
69. Tkachenko E, Sabouri-Ghomi M, Pertz O, Kim C, Gutierrez E, et al. (2011) Protein kinase A governs a RhoA-RhoGDI protrusion-retraction pacemaker in migrating cells. Nat Cell Biol 13: 660-667.
70. Pullikuth AK, Catling AD, (2007) Scaffold mediated regulation of MAPK signaling and cytoskeletal dynamics: a perspective. Cell Signal 19: 1621-1632.